Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors

Microbial Pathogenesis

Volumn 44, Issue 5, 2008, Pages 410-416

  Puolakkainen, Mirja ^a,b,c   Lee, Amy ^a   Nosaka, Tadayoshi ^a   Fukushi, Hideto ^a,d   Kuo, Cho Chou ^a   Campbell, Lee Ann ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d GIFU UNIVERSITY   (Japan)

Author keywords

Chlamydia pneumoniae; Hapten inhibition; Receptor; Retinoic acid

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; RETINOIC ACID; RETINOIC ACID RECEPTOR; SOMATOMEDIN B RECEPTOR;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; CELL GROWTH; CELL SURFACE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

BACTERIAL ADHESION; CELL LINE; CHLAMYDOPHILA PNEUMONIAE; CYTOPLASM; ENDOTHELIAL CELLS; HUMANS; INCLUSION BODIES; RECEPTOR, IGF TYPE 2; RECEPTORS, RETINOIC ACID; TRETINOIN;

ANIMALIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 42049100973     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.11.004     Document Type: Article

References (24)

1. Hackstadt T., Rockey D.D., Heinzen R.A., and Scidmore M.A. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J 5 (1996) 964-977
2. Godzik K., O'Brien E.R., Wang S.K., and Kuo C.C. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 33 (1995) 2411-2414
3. Campbell L.A., Rosenfeld M., and Kuo C.C. The role of Chlamydia pneumoniae in atherosclerosis-recent evidence from animal models. Trends Microbiol 8 (2000) 255-257
4. Kalayoglu M.V., and Byrne G.I. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 77 (1998) 725-729
5. Kalayoglu M.V., Indrawati A., Morrison R.P., Morrison S.G., Yuan Y., and Byrne G.I. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J Infect Dis 181 Suppl 3 (2000) S483-S489
6. Campbell L.A., and Kuo C.C. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis?. Nat Rev Microbiol 2 (2004) 23-32
7. Kuo C.C., Takahashi N., Swanson A.F., Ozeki Y., and Hakomori S.I. An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest 98 (1996) 2813-2818
8. Puolakkainen M., Kuo C.-C., and Campbell L.A. Mannose 6-phosphate inhibits growth of Chlamydia pneumoniae in human arterial endothelial cells. Infect Immun 78 (2005) 4620-4625
9. Kang J.X., Li Y., and Leaf A. Mannose 6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid. Proc Natl Acad Sci USA 94 (1997) 13671-13676
10. Kuo C.C., Lee A., and Campbell L.A. Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects attachment and infectivity of the organisms in human epithelial and endothelial cells. Infect Immun 72 (2004) 6699-6701
11. Campbell L.A., Lee A., and Kuo C.C. Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects infectivity in the mouse model of lung infection. Infect Immun 74 (2006) 3027-3029
12. Kang J.X., Bell J., Leaf A., Beard R.L., and Chandraratna R.A.S. Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes. Proc Natl Acad Sci USA 95 (1998) 13687-13691
13. Mangelsdorf D.J., Umesona K., and Evans R.M. The retinoids: biology, chemistry, and medicine. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds) (1994), Raven Press, New York, NY 319-349
14. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 10 (1996) 940-954
15. Isaacs C.E., Xu W., Pullarkat R.K., and Kascsak R. Retinoic acid reduces the yield of herpes simplex virus in Vero cells and alters the N-glycosylation of viral envelope proteins. Antiviral Res 47 (2000) 29-40
16. Lin T.M., Campbell L.A., Rosenfeld M.E., and Kuo C.C. Human monocyte-derived insulin-like growth factor-2 enhances the infection of human arterial endothelial cells by Chlamydia pneumoniae. J Infect Dis 183 (2001) 1368-1372
17. Crowle A.J., and Ross E.J. Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 57 (1989) 840-844
18. Beard R.L., Chandraratna R.A.S., Colon D.F., Gillett S.J., Henry E., Marler D.K., et al. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids. J Med Chem 38 (1995) 2820-2829
19. Balmer J.E., and Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 43 (2002) 1773-1808
20. Wu Y.N., Gadina M., Tao-Chen J.-H., and Youle R.J. Retinoic acid disrupts the Golgi apparatus and increases the cytosolic routing of specific protein toxins. J Cell Biol 4 (1994) 743-753
21. Murate T., Suzuki M., Hattori M., Takagi A., Kojima T., Tanizawa T., et al. Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell line. J Biol Chem 277 (2002) 9936-9943
22. Wolf K., and Hackstadt T. Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells. Cell Microbiol 3 (2001) 145-152
23. Ades E.W., Hierholzer J.C., George V., Black J., and Candal F. Viral susceptibility of an immortalized human microvascular endothelial cell line. J Virol Methods 39 (1992) 83-90
24. Perez Melgosa M., Kuo C.-C., and Campbell L.A. Outer membrane complex proteins of Chlamydia pneumoniae. FEMS Microbiol Lett 112 (1993) 199-204